<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01579695</url>
  </required_header>
  <id_info>
    <org_study_id>EMR200147-501</org_study_id>
    <nct_id>NCT01579695</nct_id>
  </id_info>
  <brief_title>Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®</brief_title>
  <official_title>A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theratechnologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theratechnologies</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this observational, 10-year, prospective cohort study is to assess the
      potential safety concerns of long-term exposure to EGRIFTA® in HIV-infected subjects with
      abdominal lipohypertrophy compared with a similar group of subjects not exposed to EGRIFTA®.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2029</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to development of malignancies in HIV-infected subjects with abdominal lipohypertrophy exposed to EGRIFTA® vs. concurrent, comparable control group not exposed to EGRIFTA®</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to development or worsening of Type 2 Diabetes Mellitus, diabetic retinopathy, hypersensitivity reactions, hepatic and renal function, adverse events and major adverse cardiovascular events</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3190</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Exposed Group will receive Tesamorelin</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group will not receive Tesamorelin</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tesamorelin for injection</intervention_name>
    <description>Daily 2 mg subcutaneous injections of Tesamorelin</description>
    <arm_group_label>Exposed Group will receive Tesamorelin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be representative of the HIV-injected population affected by
        abdominal lipohypertrophy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All of the following inclusion criteria must be fulfilled:

          1. Subject has given written informed consent;

          2. Subject is an adult man or woman ≥ 18 years old;

          3. Subject has HIV infection;

          4. Subject has physical evidence of excess abdominal fat, as determined by the examining
             study physician.

          5. Subject has completed standard of care assessments (mammography, cervical PAP smear,
             colonoscopy and blood work for HIV-1 RNA, CD4 cell count, renal, hepatic, and
             hematology, PSA test, fasting blood glucose, lipid panel ) prior to being enrolled
             onto the study.

        Exclusion Criteria:

        Exclusion criteria 1 through 4 are based on the contraindications for EGRIFTA®.

          1. Disruption of the hypothalamic-pituitary axis, including conditions such as
             hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head
             trauma;

          2. Active malignancy (newly diagnosed or recurrent)

          3. Known hypersensitivity to tesamorelin and/or mannitol

          4. Pregnancy or lactation

          5. Use of EGRIFTA® within 6 months prior to baseline

          6. Failure to complete any standard of care assessments listed in Section 5.2.1
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Claude Mamputu, PhD</last_name>
    <affiliation>Theratechnologies Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Theratechnologies Medical Information</last_name>
    <phone>1-844-347-4382</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Franco Felizarta, MD</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecilia Felizarta</last_name>
      <phone>661-324-3128</phone>
    </contact>
    <investigator>
      <last_name>Franco Felizarta, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Coast Medical Group</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Bosman</last_name>
      <phone>714-698-0300</phone>
      <phone_ext>220</phone_ext>
    </contact>
    <investigator>
      <last_name>Sujata Lalla-Reddy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California CARE Clinic, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Cajahuaringa</last_name>
      <phone>310-557-9640</phone>
    </contact>
    <investigator>
      <last_name>Jordan Lake, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tower Infectious Diseases Medical Associates</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Robertson</last_name>
      <phone>310-358-2300</phone>
    </contact>
    <investigator>
      <last_name>Cyril R. Gaultier, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oasis Clinic</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Herrigan</last_name>
      <phone>424-338-2948</phone>
    </contact>
    <investigator>
      <last_name>Wilbert Jordan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VAMC, Infectious Disease Section 111W</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Freasier</last_name>
      <phone>415-379-5518</phone>
    </contact>
    <investigator>
      <last_name>Phyllis Tien, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dupont Circle Physician's Group</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Kirkman</last_name>
      <phone>202-745-0201</phone>
    </contact>
    <investigator>
      <last_name>Douglas J. Ward, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Capital Medical Associates, PC</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Granville</last_name>
      <phone>202-822-6311</phone>
    </contact>
    <investigator>
      <last_name>Theo Hodge, Jr., M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gary J. Richmond, M.D., PA</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vernon Appleby</last_name>
      <phone>954-524-2250</phone>
      <phone_ext>211</phone_ext>
    </contact>
    <investigator>
      <last_name>Gary J. Richmond, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Kinder Medical Group-AHF</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Manrique</last_name>
      <phone>786-497-4000</phone>
      <phone_ext>232</phone_ext>
    </contact>
    <investigator>
      <last_name>Clifford A. Kinder, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orange County Health Department</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willie M. Carter</last_name>
      <phone>407-858-1436</phone>
    </contact>
    <investigator>
      <last_name>Richard Solero, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orange County Health Department</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willie Carter</last_name>
      <phone>407-858-1436</phone>
    </contact>
    <investigator>
      <last_name>Ewa Szczypinska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rowan Tree Medical, P.A.</name>
      <address>
        <city>Wilton Manors</city>
        <state>Florida</state>
        <zip>33305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avery Woodard</last_name>
      <phone>954-533-5382</phone>
    </contact>
    <investigator>
      <last_name>Jennifer Bartczak, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Absolute Care Medical Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theresa McGhee</last_name>
      <phone>404-231-4431</phone>
    </contact>
    <investigator>
      <last_name>Joel Rosenstock, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northstar Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60657</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Stokes</last_name>
      <phone>773-296-2400</phone>
      <phone_ext>126</phone_ext>
    </contact>
    <investigator>
      <last_name>Daniel Berger, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Illnois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Andoh</last_name>
      <phone>217-545-9591</phone>
    </contact>
    <investigator>
      <last_name>Janak Koirala, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewelinka Grzejka</last_name>
      <phone>617-724-9109</phone>
    </contact>
    <investigator>
      <last_name>Steven Grinspoon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Researth Institute</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaqueline Rivera</last_name>
      <phone>413-747-5566</phone>
    </contact>
    <investigator>
      <last_name>Claudia Martorell, M.D., MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Be Well Medical Center, P.C</name>
      <address>
        <city>Berkley</city>
        <state>Michigan</state>
        <zip>48072-3436</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Khan</last_name>
      <phone>248-544-9300</phone>
    </contact>
    <investigator>
      <last_name>Paul Benson, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southhampton Clinical Research, Inc. d.b.a. Central West Clinical Research</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa Allami</last_name>
      <phone>314-652-0100</phone>
      <phone_ext>829</phone_ext>
    </contact>
    <investigator>
      <last_name>David Parks, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton Healthcare, Inc.</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63139</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Swiercz</last_name>
      <phone>314-647-2200</phone>
      <phone_ext>103</phone_ext>
    </contact>
    <investigator>
      <last_name>David Prelutsky, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Jersey Unfectious Disease</name>
      <address>
        <city>Somers Point</city>
        <state>New Jersey</state>
        <zip>08244</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Freeman</last_name>
      <phone>609-927-6662</phone>
      <phone_ext>5</phone_ext>
    </contact>
    <investigator>
      <last_name>Christopher Lucasti, D.O., FACOI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University at Buffalo, State University of NY, Erie County Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sibu Nair</last_name>
      <phone>716-898-3055</phone>
    </contact>
    <investigator>
      <last_name>Alyssa Shon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ricky K. Hsu, MD, PC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik P. Mortensen</last_name>
      <phone>212-627-7560</phone>
    </contact>
    <investigator>
      <last_name>Ricky K. Hsu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Summa Health Care System</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Cunningham</last_name>
      <phone>330-375-3519</phone>
    </contact>
    <investigator>
      <last_name>Amy Hite, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74127</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy McFadden</last_name>
      <phone>918-382-3591</phone>
    </contact>
    <investigator>
      <last_name>Damon Baker, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reading Hospital and Medical Center</name>
      <address>
        <city>West Reading</city>
        <state>Pennsylvania</state>
        <zip>19611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Sheidy</last_name>
      <phone>484-628-4317</phone>
    </contact>
    <investigator>
      <last_name>Robert Jones, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Hope Foundation, Inc.</name>
      <address>
        <city>Bellaire</city>
        <state>Texas</state>
        <zip>77401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Talal Kayyal</last_name>
      <phone>713-844-8035</phone>
    </contact>
    <investigator>
      <last_name>Stanley Lewis, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Ghormley</last_name>
      <phone>214-857-1606</phone>
    </contact>
    <investigator>
      <last_name>Roger Bedimo, M.S., M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>tianna Petersen</last_name>
      <phone>214-590-0611</phone>
    </contact>
    <investigator>
      <last_name>Mamta Jain, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Austin Anderson</last_name>
      <phone>206-341-8940</phone>
    </contact>
    <investigator>
      <last_name>David Aboulafia, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2012</study_first_posted>
  <last_update_submitted>August 12, 2016</last_update_submitted>
  <last_update_submitted_qc>August 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV with lipohypertrophy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

